knowledge -WSS

knowledge

author：knowledge 2025-09-29 21:28:16 - browse：5318

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： SNAP should offer more nutrition education

WSS

BioAge raises $170M for combination therapy with Zepbound

The dental labor crisis is a moment of opportunity

Why health care costs have stayed mostly flat since 2010

KalVista pill reduced swelling 'attacks' caused by genetic disease

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Three trends to watch in biotech in 2024

focus

knowledge

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Three trends to watch in biotech in 2024

Wildfire smoke exposes gaps in outdoor worker protections

Doctors' information doesn't help them choose wisely when sick

Hollywood unions extend contract negotiations for actors

Violet CEO on training clinicians to promote more inclusive care

Sports medicine is finally prioritizing gender equality

Medicare Advantage proposed rates disappoint insurers

At least 13 dead in Texas as scorching temps continue

Prime Medicine, Myeloid Therapeutics clash over genome

hotspot

Christmas in the PICU brings some surprising joy

Why did Pfizer dish out millions for a Super Bowl ad?

What should King Charles tell the public about his cancer?

Readout LOUD podcast: How biotech is using artificial intelligence

Can sheer will power keep patients alive in their dying hours?

Medicare Advantage beneficiaries sue Humana over algorithm use

knowledge

focus

leisure time

entertainment